P087 ILEAL BIOMARKER OF INNATE IMMUNE ACTIVATION CAN PREDICT CLINICAL RESPONSE TO VEDOLIZUMAB IN CROHN’S DISEASE
| Autor: | Osterman, Mark T., Gordon, Ilyssa O., Davis, Elisabeth M., Ciorba, Matthew A., Glover, Sarah C., Abraham, Bincy P., Khan, Freeha, Shen, Bo, Yee, Eric, Allard, Felicia, Liu, Julia J. |
|---|---|
| Zdroj: | In Gastroenterology February 2019 156(3) Supplement:S59-S60 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|